Supplementary Table 2 from Attenuation of microRNA-126 Expression That Drives CD34<sup>+</sup>38<sup>−</sup> Stem/Progenitor Cells in Acute Myeloid Leukemia Leads to Tumor Eradication

XLSX file - 14KB, MicroRNAs differentially expressed between LSC and progenitors (at least 4 out of 6 patients): Upper: MicroRNA expression ratios between CD34+CD38-ALDHlow/dim (LSC) and CD34+CD38+ALDHlow/dim (malignant progenitor) populations obtained from microarray analysis. The average ratio is calculated over all 6 patients. Number of patients indicate the number of patients that show significant differential expression for that microRNA. Lower: Average and standard deviations of all ratios between LSC and malignant progenitors per patient. 'Average + Stdev' and 'Average - Stdev', average plus or minus one time the standard deviation for each individual patient indicate the values used as cutoff for significant microRNAs per patients. Italic printed ratios represent non-significant microRNAs for that individual patient.